ClinicalTrials.gov
ClinicalTrials.gov Menu

TMC278-TiDP6-C153 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC278 and Raltegravir

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01288755
Recruitment Status : Completed
First Posted : February 2, 2011
Last Update Posted : June 27, 2011
Sponsor:
Collaborator:
Raltegravir is provided by Merck.
Information provided by:
Tibotec Pharmaceuticals, Ireland

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : May 2011